VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $5,912,000 | -41.6% | 310,354 | -48.3% | 0.04% | -48.8% |
| Q1 2018 | $10,116,000 | +57.0% | 600,354 | +41.6% | 0.09% | +53.6% |
| Q4 2017 | $6,443,000 | -15.1% | 423,884 | 0.0% | 0.06% | -9.7% |
| Q3 2017 | $7,588,000 | +45.9% | 423,884 | +3.4% | 0.06% | +34.8% |
| Q2 2015 | $5,201,000 | -68.0% | 409,881 | -76.6% | 0.05% | -65.9% |
| Q1 2015 | $16,277,000 | -74.6% | 1,750,230 | -60.9% | 0.14% | -79.4% |
| Q4 2014 | $64,041,000 | +41.1% | 4,472,153 | +2.3% | 0.65% | +14.3% |
| Q3 2014 | $45,383,000 | -35.8% | 4,372,153 | 0.0% | 0.57% | -33.9% |
| Q2 2014 | $70,741,000 | -2.1% | 4,372,153 | -1.7% | 0.87% | -5.7% |
| Q1 2014 | $72,243,000 | +21.5% | 4,445,696 | -7.2% | 0.92% | +9.5% |
| Q4 2013 | $59,459,000 | +13.3% | 4,791,179 | 0.0% | 0.84% | +12.3% |
| Q3 2013 | $52,463,000 | +63.7% | 4,791,179 | +20.8% | 0.75% | +17.7% |
| Q2 2013 | $32,047,000 | – | 3,966,179 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |